ACC CardiaCast: Mechanisms of Action for the Newly Approved Cardiac Myosin Inhibitor Recently Approved for HCM
Listen now
Description
In this episode, Drs. Matt Martinez and Ahmad Masri discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and mechanisms of action.
More Episodes
Dive into the Heart of ACC.24's Heart Failure and Transplant Highlights! In this podcast, Drs. Maya Guglin, Shelley Hall, Onyedika Ilonze, and Kazuhiko Kido dissect the most captivating advancements and groundbreaking revelations from the ACC.24 sessions in heart failure and transplant, including...
Published 05/06/24
In this episode, Drs. Erin Michos and Leslie Cho discuss the research presented at ACC.24 related to statin intolerance and bempedoic acid. Dr. Cho’s research publication “Characteristics and Outcomes for Statin Intolerant Women Receiving Bempedoic Acid in The Clear Outcomes Trial” is discussed,...
Published 04/29/24
Published 04/29/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
